Conventional imaging for staging PCa includes computed tomography (CT), magnetic resonance imaging (MRI), and 99mTc-labeled phosphate bone scintigraphy, all of which have low sensitivity compared to PSMA PET, particularly at low PSA levels [6]. Here, FOLH1 is linked to posterior cortical atrophy.